Andrew Chadeayne, PhD, JD
Andrew Chadeayne stands apart from other patent professionals because he brings together expertise in science, entrepreneurship, and patent law. He holds PhD and JD degrees. Dr. Chadeayne studied chemistry under the world’s best academic chemists. He is an inventor and entrepreneur, with experience taking ideas to market.
Dr. Chadeayne is an accomplished scientist. He earned BA in chemistry from Princeton University in 2001 and a PhD in chemistry from Cornell University in 2006. At Princeton, he published work in neuroscience, showing the addictive nature of sugar. At Cornell, he worked with virtually every naturally occurring element on the periodic table, publishing work in organic synthesis, inorganic synthesis, surface science, and materials science. His training under Peter T. Wolczanski left him with a true mastery in the art of breaking problems into their fundamental underpinnings. As later described by his colleagues in patent law, “Andrew is the guy to call with science questions.”
Dr. Chadeayne is an inventor on numerous chemical patents, some of which have served as the basis for start-up companies. Dr. Chadeayne is the founder of SwimSpray, LLC, which utilizes his patent-pending vitamin C technology to eliminate swimmers’ longstanding chlorine problems. Dr. Chadeayne tells his story of inventing SwimSpray in the video below:
Patent Law Expertise
Dr. Chadeayne received his law degree from the George Washington University Law School, where he studied patent law under Randall R. Rader, Chief Judge of the Court of Appeals for the Federal Circuit. Dr. Chadeayne was awarded the American Bar Association’s award for excellence in patent law in 2011.
Dr. Chadeayne has eleven years experience as a patent practitioner, working with innovators of all sizes–ranging from Fortune 500 pharmaceutical companies to independent inventors. Dr. Chadeayne worked as a patent agent and science advisor at Finnegan, LLP (a Tier One IP Law Firm), where he was trained in patent prosecution by Charles E. Van Horn.
Dr. Chadeayne served as Director of Intellectual Property for NewMarket Pharmaceuticals, LLC from 2011 to 2013. At NewMarket, Dr. Chadeayne developed a patent portfolio for a suite of drug formulations.